Skip to main content
. 2016 Aug 10;7(37):60230–60244. doi: 10.18632/oncotarget.11176

Figure 6. CXCR4 activates the RhoA signaling pathway via Gα13.

Figure 6

(A) Western Blot showing the levels of Gα12 and Gα13 in transfected HCT116 and SW480 cells. GAPDH served as the internal control. (B, C) In vitro co-immunoprecipitation (co-IP) confirmed the interactions between CXCR4, RhoA, and the Gα12/Gα13 complex and revealed a complex composed of CXCR4 and Gα13. Total protein was extracted from untransfected HCT116 and SW480 cells. Total (input) and eluted (co-IP) proteins were subjected to Western Blot, which was performed with anti-Gα12, anti-RhoA, and anti-Gα13. (D) Western Blot was used to confirm the expression of Gα13 (right), and the G-LISA assay was used to measure RhoA activity in HCT116 cells after knocking down Gα13 expression with siRNA-Gα13 (left). The control group was exposed to the non-specific siRNA, **p < 0.01.